| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 08/01/2007 | CN101006999A Therapeutic methods and compositions involving isoflavones |
| 08/01/2007 | CN101006817A Bamboo leaf tea and its producing method |
| 07/31/2007 | US7250446 For prophylaxis and therapy of medical indications associated with estrogen dependent diseases or syndromes related to osteoporosis, bone loss, bone formation, cardiovascular disorders, neurodegenerative disorders, menopausal disorders, physiological disorders, diabetes disorders, prostatic carcinoma |
| 07/31/2007 | US7250440 (Hydroxyphenyl)-1H-indole-3-carbaldehyde oxime derivatives as estrogenic agents |
| 07/31/2007 | US7250399 Compounds having growth hormone releasing activity |
| 07/31/2007 | US7250272 Signal transduction membrane protein for diagnosis, prevention and treatment of central nervous system, endocrine, metabolic and cancer |
| 07/31/2007 | CA2100745C Amylin agonist peptides and uses therefor |
| 07/26/2007 | WO2007083823A1 Androgen receptor-binding activity of genoderma mushroom-treated product |
| 07/26/2007 | WO2007083145A1 The treatment of ocular conditions and the systemic side-effects of glucocorticoids |
| 07/26/2007 | WO2007065942A3 Bis-heterocyclic imidazolyl compounds |
| 07/26/2007 | WO2007025780A3 Aldosterone receptor antagonists |
| 07/26/2007 | US20070173548 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 07/26/2007 | US20070173502 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
| 07/26/2007 | US20070173454 Administering an agent that decreases or regulates the blood level, production, function or activity of gonadotropins-leutinizing hormone, follicle stimulating hormone, activin or follistatin; parkinson's disease |
| 07/26/2007 | US20070173436 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 07/26/2007 | DE102006003508A1 Arzneimittel umfassend eine Hormonkombination A pharmaceutical composition comprising a combination hormone |
| 07/26/2007 | DE102005059222A1 11ß-Benzaldoximderivate von D-Homoestra-4,9-dien-3-onen 11ß-Benzaldoximderivate of D-Homoestra-4,9-dien-3-ones |
| 07/25/2007 | EP1810677A1 Receptor function regulating agent |
| 07/25/2007 | EP1809648A2 Glucocorticoid 16alpha,17.alpha.-isoxazolidines as anti-inflammatory agents |
| 07/25/2007 | EP1809602A1 Indole derivatives useful as progesterone receptor modulators |
| 07/25/2007 | EP1809594A1 Estrogen receptor modulators |
| 07/25/2007 | EP1809271A2 (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 07/25/2007 | EP1809240A2 Cardiac safe, rapid medication delivery |
| 07/25/2007 | EP1177187B1 Di-aryl acid derivatives as ppar receptor ligands |
| 07/25/2007 | EP1042352B1 Androgenic steroid compounds and a method of making and using the same |
| 07/25/2007 | CN1328381C GnRH-leukotoxin chimeras |
| 07/25/2007 | CN1328285C Inhibitor of stem cell proliferation and uses thereof |
| 07/25/2007 | CN101006099A Thyrotropin receptor preparations, binding regions thereof, antibody and hormone interactions therewith, and uses thereof |
| 07/25/2007 | CN101005855A Methods of treating CCR2 mediated diseases or disorders |
| 07/25/2007 | CN101002897A Medicine for treating proganital lichen sclerosus disease |
| 07/25/2007 | CN101002796A Application of nanometer montmorillonite for pharmaceutical use, and medicine compositions therewith |
| 07/24/2007 | US7247624 e.g. 5-Benzyloxy-2-(4-benzyloxy-phenyl)-3-methyl-1H-indole or salts for treating colon cancer |
| 07/19/2007 | WO2007079681A1 Pyrazole carboxamide derivatives, pharmaceutical compositions and its preparation |
| 07/19/2007 | WO2007031333A3 Improvements in or relating to amphoteric liposomes |
| 07/19/2007 | WO2006128083A3 Human proislet peptide, derivatives and analogs thereof, and methods of using same |
| 07/19/2007 | US20070167503 Substituted benzoxazoles as estrogenic agents |
| 07/19/2007 | US20070167457 2-(2-(4-Fluoro)phenoxyethyl)-1-((4-(2-methyl-5-phenyl)thiazolyl)carbonyl)-4-trifluoroacetylpiperazine; antidiabetic agent; non-insulin dependent diabetes, obesity, sleep disorder |
| 07/19/2007 | US20070167445 Androgen receptor modulator compounds and methods |
| 07/19/2007 | US20070167364 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 07/19/2007 | US20070166410 Follicle-stimulating hormone releasing agent |
| 07/18/2007 | EP1808429A2 Hydroxy-biphenyl-carbaldehyde oxime derivatives and their use as estrogenic agents |
| 07/18/2007 | EP1808172A2 Botanical extract compositions and methods of use |
| 07/18/2007 | EP1807065A2 Methods and compositions for treating nephrogenic diabetes insipidus |
| 07/18/2007 | EP1383482B1 Method for manufacturing a low dose pharmaceutical composition |
| 07/18/2007 | CN1326855C Ring fused pyrazole derivatives |
| 07/18/2007 | CN1326563C Use of the long pentraxin PTX3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 07/18/2007 | CN1326529C Relaxation of Climacteric syndrome by using antisenility action of glossy ganoderma |
| 07/18/2007 | CN101001640A 缓释组合物 Sustained release composition |
| 07/18/2007 | CN101001625A Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof |
| 07/17/2007 | US7244846 Substituted benzofuran-2-carboxamides derivatives |
| 07/17/2007 | US7244746 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 07/17/2007 | US7244709 comprising an aqueous mixture of parathyroid hormone, a cyclodextran and didecanoylphosphatidylcholine at concentrations sufficient to enhance permeation across the cellular layer, wherein the formulation consists of droplets, of which less than 10% are less than 10 microns in diameter |
| 07/17/2007 | US7244429 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 07/17/2007 | US7244414 Administering fine powder of active material; measured aerosol |
| 07/12/2007 | WO2007077741A1 Transdermally absorbable preparation |
| 07/12/2007 | WO2007077252A1 Concentrated liquid thyroid hormone composition |
| 07/12/2007 | WO2007062874A3 Sulfamoyl sulfonate prodrugs |
| 07/12/2007 | WO2006074957A9 Substituted aminomethylene sulphonamides, production and use thereof as medicaments |
| 07/12/2007 | US20070161666 Pyrrolo[2,3-d]pyrimidine compounds |
| 07/12/2007 | US20070161635 Kinase inhibitors |
| 07/12/2007 | US20070161063 Identifying, monitoring, and treating women for breast precancer or cancer |
| 07/12/2007 | US20070160603 Antibodies Against Tumor Necrosis Factor Delta (APRIL) |
| 07/12/2007 | US20070160594 Method of Diagnosing and Treating Cartilaginous Disorders |
| 07/12/2007 | CA2634993A1 Concentrated liquid thyroid hormone composition |
| 07/11/2007 | EP1806404A1 Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 07/11/2007 | EP1806347A1 Aromatic-ring-fused pyrimidine derivative |
| 07/11/2007 | EP1805201A1 15b-substituted steroids having selective estrogenic activity |
| 07/11/2007 | EP1805147A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 07/11/2007 | EP1805135A2 Purification of cinacalcet |
| 07/11/2007 | EP1248784B1 Condensed azepines as vasopressin agonists |
| 07/11/2007 | EP1175398B1 Indoline derivatives as progesterone antagonists |
| 07/11/2007 | EP1154788B1 Inhibitors of separin, method for identifying them and uses |
| 07/11/2007 | EP0998291B1 Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 07/11/2007 | CN1997659A D-homo-17-chloro-16(17)en steroids |
| 07/11/2007 | CN1997618A Compounds with activity at estrogen receptors |
| 07/11/2007 | CN1997403A Mitochondrially targeted antioxidants in the treatment of liver diseases and epithelial cancers |
| 07/11/2007 | CN1997349A Film-shaped estriol-containing medicament for oral administration |
| 07/11/2007 | CN1995039A Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 07/11/2007 | CN1325650C Delivery system for porcine somatotropin |
| 07/11/2007 | CN1325507C 17alpha-alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations |
| 07/10/2007 | US7241923 Phenylalkyloxy-phenyl derivatives |
| 07/10/2007 | US7241793 For therapy of cardiovascular diseases |
| 07/10/2007 | US7241791 Substituted 4-(indazol-3-yl)phenols |
| 07/10/2007 | US7241782 Modifications are prepared by subjecting an alkaline solution of torasemide to a rapid acidification with inorganic or organic acids at 0 to 35 degrees C. |
| 07/10/2007 | US7241777 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors |
| 07/10/2007 | US7241738 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/10/2007 | US7241733 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 07/10/2007 | CA2396814C Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical compositions containing them |
| 07/10/2007 | CA2378628C New indenoindolone derivatives, the process for preparing them and the pharmaceutical compounds that contain them |
| 07/05/2007 | WO2007075884A2 Androgen receptor modulator compounds and methods |
| 07/05/2007 | US20070157326 Ee3-protein family and corresponding dna sequence |
| 07/05/2007 | US20070155955 Amylin aggregation inhibitors and use thereof |
| 07/05/2007 | US20070155808 G Protein-Coupled Receptors (GPR40); insulin secretagogue; diabetes; 3-[4-[[4-[[(2-Phenylethyl)(4-phenyl-1,3-thiazol-2-yl)amino]methyl]benzyl]oxy]phenyl]propanoic acid |
| 07/05/2007 | US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents |
| 07/05/2007 | US20070154401 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 07/05/2007 | US20070154400 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 07/05/2007 | US20070154392 treating a cancerous disease which includes characterizing a disease by an overexpression of one or more somatostatin receptors, exposing such somatostatin receptors to a pharmaceutical formulation containing a somatostatin analogue which binds to the one or more somatostatin receptor |
| 07/05/2007 | CA2635575A1 Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof |
| 07/05/2007 | CA2634437A1 4,7-dihydrothieno¬2,3-b|pyridine compounds and pharmaceutical compositions |
| 07/04/2007 | EP1803730A1 Albumin fusion proteins |